BeStock  
Stocks › Biotechnology › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2295Biotechnology
$73.01 −$4.66 (-6.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $71.00 -2.75%
Open$77.09
Prev close$77.67
Day range$72.57 – $78.11
Volume706.8K
Market cap$3.60B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$194.57M+63.9% YoY
Operating profit-$663.71M-4,468.2% YoY
Net profit-$668.33M-5,210.6% YoY
Diluted EPS-$14.40-4,700.0% YoY
Free cash flow-$44.51M-372.3% YoY
Operating cash flow-$6.00M

Revenue, last 8 quarters

$66.4MDec '24$78.3MMar '25$102.7MJun '25$118.7MSep '25$151.7MDec '25$162.1MMar '26$173.9MJun '26$194.6MSep '26

Net profit, last 8 quarters

$-23.1MDec '24$-25.1MMar '25$-20.3MJun '25$-12.6MSep '25$-8.4MDec '25$-7.0MMar '26$-18.6MJun '26$-668.3MSep '26

Diluted EPS by quarter

-0.60Dec '24-0.64Mar '25-0.48Jun '25-0.30Sep '25-0.20Dec '25-0.16Mar '26-0.43Jun '26-14.40Sep '26

Free cash flow by quarter

$-27.3MDec '24$-21.2MMar '25$-30.4MJun '25$16.3MSep '25$13.0MDec '25$-30.5MMar '26$57.2MJun '26$-44.5MSep '26

Annual revenue

$0.0FY20$57.0MFY21$25.8MFY22$17.4MFY23$183.0MFY24$451.4MFY25

Profitability & balance sheet

Gross margin93.2%
Operating margin-102.3%
Net margin-102.9%
Return on equity-319.8%
Return on assets-135.0%
Return on invested capital-241.8%
Current ratio1.96
Liabilities / assets79.4%
Cash & investments$309.61M
Total debt$72.94M
Net cash (debt)$236.68M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $194.57M $173.91M $162.05M $451.36M $151.67M
Total Operating Revenue $194.57M $173.91M $162.05M $451.36M $151.67M
Cost of Revenue $13.89M $12.11M $9.40M $30.68M $10.93M
Gross Profit $180.68M $161.80M $152.66M $420.68M $140.74M
Operating Expense $844.39M $181.71M $158.78M $491.65M $148.72M
Selling and Admin Expenses $168.02M $150.70M $136.43M $427.32M $130.68M
Research & Development $676.37M $31.01M $22.35M $64.32M $18.04M
Operating Profit -$663.71M -$19.91M -$6.12M -$70.97M -$7.98M
Net Non-Operating Interest Income (Expense) $1.59M $1.54M $1.59M $6.81M $1.74M
Non-Operating Interest Income $3.78M $3.70M $3.72M $15.75M $3.95M
Non-Operating Interest Expense $2.01M $1.99M $1.97M $8.34M $2.06M
Total Other Finance Costs $172,000.00 $165,000.00 $159,000.00 $593,000.00 $156,000.00
Other Income (Expense) -$1.57M $2.53M -$87,000.00 -$202,000.00 -$74,000.00
Special Income (Charges) -$1.66M – – $0.00 $0.00
-Less:Restructuring and Mergern & Acquisition $1.66M – – – –
Other Non-Operating Income (Expenses) $91,000.00 -$281,000.00 -$87,000.00 -$202,000.00 -$74,000.00
Pretax Profit -$663.69M -$15.84M -$4.62M -$64.36M -$6.31M
Tax $4.64M $2.72M $2.35M $2.06M $2.06M
Net Profit -$668.33M -$18.55M -$6.97M -$66.42M -$8.37M
Profit from Continuing Operations -$668.33M -$18.55M -$6.97M -$66.42M -$8.37M
Net Income to Parent Company -$668.33M -$18.55M -$6.97M -$66.42M -$8.37M
Net Income to Common Stockholders -$668.33M -$18.55M -$6.97M -$66.42M -$8.37M
Basic EPS -$14.40 -$0.43 -$0.16 -$1.59 -$0.20
Diluted EPS -$14.40 -$0.43 -$0.16 -$1.59 -$0.20
Gain on Sale of Security – $2.81M – – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $505.50M $611.14M $581.14M $562.16M $562.16M
Total Current Assets $445.42M $561.99M $537.23M $522.78M $522.78M
Cash and Cash Equivalents & Short-Term Investments $309.61M $449.69M $388.73M $417.27M $417.27M
-Cash and Cash Equivalents $136.53M $204.60M $102.19M $183.64M $183.64M
-Short Term Investments $173.08M $245.10M $286.54M $233.63M $233.63M
Receivables $102.11M $98.31M $117.21M $87.11M $87.11M
-Accounts Receivable $100.44M $96.03M $100.34M $85.06M $85.06M
-Other Receivables $1.67M $2.28M $16.86M $2.05M $2.05M
Prepaid Assets $28.54M $9.61M $26.72M $13.47M $13.47M
Inventory $5.16M $4.38M $4.57M $4.37M $4.37M
Restricted Cash $0.00 $0.00 $0.00 $560,000.00 $560,000.00
Total Non-Current Assets $60.08M $49.15M $43.91M $39.38M $39.38M
Net PPE $31.11M $30.40M $27.67M $21.75M $21.75M
-Gross PPE $33.84M $32.25M $29.96M $23.84M $23.84M
-Accumulated Depreciation -$2.73M -$1.85M -$2.30M -$2.10M -$2.10M
Investments and Advances $6.68M $6.68M $3.87M $3.87M $3.87M
Goodwill and Other Intangible Assets $16.65M $6.89M $7.13M $7.37M $7.37M
Other Non-Current Assets $5.64M $5.19M $5.24M $6.40M $6.40M
Total Liabilities $401.47M $264.41M $232.18M $218.73M $218.73M
Total Current Liabilities $227.11M $175.75M $143.51M $135.70M $135.70M
Payables $52.16M $51.64M $31.96M $27.30M $27.30M
-Accounts Payable $34.69M $40.14M $24.13M $16.39M $16.39M
-Total Tax Payable $5.67M $2.11M $563,000.00 $1.81M $1.81M
-Other Payable $11.80M $9.39M $7.27M $9.10M $9.10M
Current Accrued Expenses $122.01M $98.69M $79.05M $86.22M $86.22M
Other Current Liabilities $52.94M $25.43M $32.50M $22.18M $22.18M
Total Non-Current Liabilities $174.36M $88.66M $88.68M $83.04M $83.04M
Long Term Debt and Capital Lease Obligation $72.94M $72.76M $72.60M $72.44M $72.44M
-Long Term Debt $72.94M $72.76M $72.60M $72.44M $72.44M
Other Non-Current Liabilities $101.42M $15.90M $16.08M $10.60M $10.60M
Total Equity $104.03M $346.73M $348.95M $343.43M $343.43M
Stockholders' Equity $104.03M $346.73M $348.95M $343.43M $343.43M
Capital Stock $7,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $7,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.23B $799.43M $782.84M $769.67M $769.67M
Retained Earnings -$1.12B -$452.15M -$433.60M -$426.63M -$426.63M
Gains/Losses Not Affecting Retained Earnings -$914,000.00 -$557,000.00 -$298,000.00 $381,000.00 $381,000.00
-Current Capital Lease Obligation – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$6.00M $61.22M -$24.65M -$12.45M $19.33M
Net cash flow from continuing operations -$6.00M $61.22M -$24.65M -$12.45M $19.33M
Net Income from Continuing Operations -$668.33M -$18.55M -$6.97M -$66.42M -$8.37M
Gain/Loss from Continuing Operations $1.67M – – – –
Depreciation & Depletion & Amortization $1.03M $1.00M $437,000.00 $1.82M $443,000.00
Other Non-Cash Items $632.48M $258,000.00 $236,000.00 $1.28M $310,000.00
Change in Working Capital -$2.66M $68.63M -$29.48M $14.64M $13.58M
-Change in Receivables -$3.80M $18.92M -$30.10M -$39.05M -$12.77M
-Change in Inventory -$781,000.00 $198,000.00 -$196,000.00 -$1.75M -$536,000.00
-Change in Prepaid Assets -$16.70M $17.11M -$13.24M $1.72M $8.19M
-Change in Payables and Accrued Expense $2.38M $19.05M -$1.54M $8.86M $19.20M
-Change in Other Current Assets -$77,000.00 $55,000.00 $141,000.00 -$527,000.00 -$381,000.00
-Change in Other Current Liabilities $16.32M $13.30M $15.46M $45.39M -$119,000.00
Net cash flow from investing -$189.49M $37.88M -$58.56M -$42.12M $49.27M
Net Cash Flow from Continuing Investing Activities -$189.49M $37.88M -$58.56M -$42.12M $49.27M
Net PPE Purchase and Sale -$1.21M -$4.07M -$5.82M -$9.86M -$6.36M
Net Investment Purchase and Sale -$150.99M $41.95M -$52.74M -$32.26M $55.63M
Financing Cash Flow $127.81M $3.30M $1.20M $143.39M $2.31M
Net Cash Flow from Continuing Financing Activities $127.81M $3.30M $1.20M $143.39M $2.31M
Net Common Stock Issuance $113.14M $0.00 $0.00 $134.77M $0.00
Proceeds from Stock Option Exercised $7.48M $3.30M $1.20M $8.62M $2.31M
Ending Cash Balance $138.91M $206.60M $104.19M $186.20M $186.20M
Net Change in Cash -$67.68M $102.40M -$82.01M $88.82M $70.92M
Beginning Cash Balance $206.60M $104.19M $186.20M $97.38M $115.29M
Free Cash Flow -$44.51M $57.15M -$30.47M -$22.31M $12.97M
Net Intangibles Purchase and Sale – – – $0.00 $0.00
Net Issuance Payments Of Debt – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on TARS.

Sign in to join the discussion.

Scroll to Top